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MOUSE MODEL OF 
WERNER SYNDROME 
Table 1. Summary of phenotypes observed in the Wrn+/+ 
Terc-/- and Wrn-/- Terc-/- mouse models 
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*Telomerase null animals display a subset of aging phenotypes but do 
  not display many of the symptoms associated with human aging.  
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2. Telomerase activity 
 
 
 
 
 
 
3. Redundant function of murine WRN  
 
 
 
 
4. Inter-individual differences  
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FISH analysis of WS cells. 
Telomeres were hybridized with a 
TRITC-[TTAGGG]4 probe and are 
shown in the red channel. Arrows 
indicate missing telomeric staining 
from single sister chromatids. 
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TELOMERE DYSFUNCTION CONTRIBUTES TO WS PATHOLOGY 
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WRN INTERACTS WITH RESIDENT TELOMERIC PROTEINS 
 
 
 
    Werner Syndrome (WS) is a rare genetic disorder that mimics 
the characteristics of normal human aging. Since aging is likely 
caused by numerous genetic and environmental factors acting 
simultaneously, it is very difficult to dissect the roles of individual 
genes in this process. In order to simplify such complexity, the 
goal of this review is focused on the relationship between three 
key components: aging, telomeres and the enzyme telomerase, 
taking Werner syndrome as a model of human aging. 
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Both shortened telomeres 
and a lack of telomerase 
are required, at least in 
mice, for WS disease 
manifestation.  
FUTURE APPROACHES 
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DIFFERENT STUDIES EXEMPLIFY THIS INTERDEPENDENT FUNCTION BETWEEN WRN AND TELOMERASE: 
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DRUG INTERVENTION IN PREVENTING ACCELERATED 
AGING IN WS 
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Because of their G-rich nature, 
telomeres are fraught with 
potential obstacles to DNA 
replication that block replication 
forks. WRN is capable of 
unwinding such structures, 
preventing collapse in telomere 
forks. In its absence, telomeric 
signals are only detected at a 
single chromatid, phenotype 
termed sister telomere loss 
(STL).  
 
WRN participates in several important DNA metabolic pathways. These include 
DNA repair, replication, recombination and telomere maintenance. WRN plays a 
role at telomeres as it interactions with other resident telomeric proteins.  
Elevated stress response 
correlates with the activation 
of the stress-associated 
mitogen-activated protein 
kinase (MAPK) p38. 
Activation of p38 stabilizes 
p21 and promotes entry into 
cellular senescence. 
SB203580 is a drug that 
targets p38 activity. This drug 
treatment extends the 
replicative lifespan of WS 
fibroblasts in vitro.   
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WERNER SYNDROME AS A MODEL OF HUMAN AGING Main features Molecular level 
Bilateral cataracts 
Greying hair and hair loss 
Short stature 
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Atherosclerosis 
Ischemic heart disease  
Osteoporosis 
Type II diabetes mellitus 
Hypogonadism 
Cancer predisposition 
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SYNDROME 
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WRN loss induces the wide range of premature aging phenotypes seen in Werner Syndrome. 
   
The key event, caused by WRN mutations, is the dysfunction of telomeres. Thus, the cascade started by 
telomere dysfunction explains the majority of the WS pathological phenotypes.  
   
Telomerase phenotypes recruitment as well as the WS mouse model generation reinforce this hypothesis.  
 
The SB203580 drug treatment may lead to novel therapies involving MAPK.  
 
 
